FREE subscriptions for doctors and students... click here
You have 3 more open access pages.
A prospective open cohort study has examined and quantified the unintended
risks and benefits of statins in a large representative primary care population
over a six year period.
With respect to statin treatment and association with acute renal failure
- risk of acute renal failure was increased in both men and women prescribed
simvastatin, atorvastatin, and pravastatin and in women prescribed fluvastatin.
The magnitudes of the adjusted hazard ratios were similar for each statin,
ranging from 1.50 to 2.19, and direct comparisons showed no difference in
risk by type of statin (P=0.91 in men, P=0.37 in women)
- NNH for an additional case of acute renal failure over five years was 434
(284 to 783)
Last reviewed 01/2018